Ephraim Fields revealed that they own a 5.8% stake in Arotech Corp. (NASDAQ:ARTX) in a Schedule 13D/A disclosure that was filed with the Securities and Exchange Commission (SEC) on Friday, October 7th. The investor owns 1,546,065 shares of the stock worth about $5,117,475. The filing is available through Edgar at this link.
Several other institutional investors also recently bought and sold shares of the company. TFS Capital LLC acquired a new stake in Arotech Corp. during the second quarter worth about $138,000. Spark Investment Management LLC raised its stake in Arotech Corp. by 510.8% in the second quarter. Spark Investment Management LLC now owns 158,800 shares of the company’s stock worth $446,000 after buying an additional 132,800 shares during the period. Cannell Capital LLC acquired a new stake in Arotech Corp. during the second quarter worth about $938,000. Oxford Asset Management acquired a new stake in Arotech Corp. during the second quarter worth about $971,000. Finally, Dimensional Fund Advisors LP raised its stake in Arotech Corp. by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 472,215 shares of the company’s stock worth $1,327,000 after buying an additional 11,609 shares during the period. 16.00% of the stock is owned by hedge funds and other institutional investors.
Shares of Arotech Corp. (NASDAQ:ARTX) traded up 0.91% during midday trading on Friday, hitting $3.34. 241,901 shares of the stock were exchanged. The firm has a 50 day moving average of $2.92 and a 200 day moving average of $2.93. The firm’s market cap is $84.78 million. Arotech Corp. has a 12-month low of $1.32 and a 12-month high of $4.13.
Arotech Corp. (NASDAQ:ARTX) last announced its earnings results on Monday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.02. Arotech Corp. had a positive return on equity of 2.25% and a negative net margin of 1.70%. The firm earned $21.80 million during the quarter, compared to analyst estimates of $21.60 million. Equities analysts forecast that Arotech Corp. will post ($0.09) EPS for the current fiscal year.
A number of research firms have issued reports on ARTX. B. Riley reiterated a “buy” rating and set a $4.50 target price on shares of Arotech Corp. in a report on Tuesday, August 9th. Zacks Investment Research lowered shares of Arotech Corp. from a “hold” rating to a “sell” rating in a report on Thursday, August 11th. Finally, TheStreet upgraded shares of Arotech Corp. from a “sell” rating to a “hold” rating in a report on Thursday, July 7th.
In other news, Chairman Jon B. Kutler bought 10,000 shares of the firm’s stock in a transaction dated Monday, August 22nd. The stock was purchased at an average price of $2.60 per share, with a total value of $26,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 17.30% of the stock is owned by insiders.
Arotech Corp. Company Profile
Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division.
Want to see what other hedge funds are holding ARTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arotech Corp. (NASDAQ:ARTX).
Receive News & Ratings for Arotech Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech Corp. and related companies with MarketBeat.com's FREE daily email newsletter.